Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Other financing activities (2009 - 2026)

Bio-Techne (TECH) posted quarterly Other financing activities of $30.0 million for Q1 2026, up 101.45% year-over-year from $14.9 million in Q1 2025, and up 532.18% quarter-over-quarter from $4.7 million in Q4 2025.

Analysis

Bio-Techne (TECH) Other financing activities (2009 - 2026) Analysis & Trends

Bio-Techne's Other financing activities history runs 18 years deep, the most recent figure standing at $30.0 million for Q1 2026.

  • In Q1 2026, Other financing activities rose 101.45% year-over-year to $30.0 million; the TTM figure through Mar 2026 stood at $64.4 million (down 5.88% YoY), while the FY2025 annual figure was $51.7 million, down 15.09% from the prior year.
  • Other financing activities for Q1 2026 stood at $30.0 million, up from $4.7 million in the prior quarter.
  • The five-year high for Other financing activities was $32.3 million in Q2 2023, with the low at -$67.6 million in Q2 2022.
  • The 5-year median for Other financing activities is $14.4 million (2023), against an average of $8.0 million.
  • Peak annual rise in Other financing activities reached 685.84% in 2023, while the deepest fall reached 671.59% in 2023.
  • Bio-Techne's Other financing activities stood at $19.4 million in 2022, then slumped by 72.85% to $5.3 million in 2023, then rose by 5.0% to $5.5 million in 2024, then decreased by 14.46% to $4.7 million in 2025, then jumped by 532.18% to $30.0 million in 2026.
  • Business Quant data shows TECH's Other financing activities at $30.0 million in Q1 2026, $4.7 million in Q4 2025, and $23.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.43 Mn
Mar 31, 2026 29.96 Mn
Dec 31, 2025 4.74 Mn
Sep 30, 2025 23.50 Mn
Jun 30, 2025 6.23 Mn
Mar 31, 2025 14.87 Mn
Dec 31, 2024 5.54 Mn
Sep 30, 2024 25.10 Mn
Jun 30, 2024 22.93 Mn
Mar 31, 2024 18.33 Mn
Dec 31, 2023 5.28 Mn
Sep 30, 2023 14.39 Mn
Jun 30, 2023 8.41 Mn
Mar 31, 2023 4.42 Mn
Dec 31, 2022 5.03 Mn
Sep 30, 2022 11.95 Mn
Jun 30, 2022 8.81 Mn
Mar 31, 2022 3.40 Mn
Dec 31, 2021 6.10 Mn
Sep 30, 2021 37.88 Mn